Aricept Vascular Dementia Study Yields Unexpectedly High Mortality
This article was originally published in The Pink Sheet Daily
Executive Summary
Despite high mortality rate in study of Pfizer/Eisai’s donepezil for vascular dementia, combined analysis shows no statistically significant difference in mortality rates.